Weight loss jabs may achieve less drastic results outside trials, study suggests
by Nicola Davis Science correspondent from Science | The Guardian on (#6Y1HZ)
Patients in real world shed less weight than in clinical settings and may benefit more from bariatric surgery
People using weight loss jabs shed far fewer pounds in the real world than in clinical trials, researchers have found.
Jabs such as Wegovy and Mounjaro, which contain the drugs semaglutide and tirzepatide respectively, have transformed the treatment of obesity, with studies suggesting the former can help people lose up to 20% of their body weight after 72 weeks of treatment.
Continue reading...